← Back to All US Stocks

PRF Technologies Ltd. (PRFX) Fundamental Analysis & AI Grade 2026

PRFX Nasdaq Pharmaceutical Preparations L3 CIK: 0001801834
Recently Updated • Analysis: Jul 13, 2026 • SEC Data: 2026-07-13

PRF Technologies Ltd. (PRFX) Financial Metrics & Key Ratios

Revenue
N/A
Net Income
N/A
EPS (Diluted)
$0.00
Free Cash Flow
N/A
Total Assets
N/A
Cash Position
N/A

💡 AI Analyst Insight

The current ratio below 1.0x warrants monitoring of short-term liquidity.

PRFX Profit Margin, ROE & Profitability Analysis

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROE N/A
ROA N/A
FCF Margin N/A

PRFX vs Healthcare Sector: How PRF Technologies Ltd. Compares

How PRF Technologies Ltd. compares to Healthcare sector averages

Net Margin
PRFX 0.0%
vs
Sector Avg 12.0%
PRFX Sector
ROE
PRFX 0.0%
vs
Sector Avg 15.0%
PRFX Sector
Current Ratio
PRFX 0.0x
vs
Sector Avg 2.0x
PRFX Sector
Debt/Equity
PRFX 0.0x
vs
Sector Avg 0.6x
PRFX Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is PRF Technologies Ltd. Stock Overvalued? PRFX Valuation Analysis 2026

Based on fundamental analysis, PRF Technologies Ltd. has mixed fundamental signals relative to the Healthcare sector in 2026.

Return on Equity
N/A
Sector avg: 15%
Net Profit Margin
N/A
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
N/A
Sector avg: 0.6x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

PRF Technologies Ltd. Balance Sheet: PRFX Debt, Cash & Liquidity

Current Ratio
N/A
Quick Ratio
N/A
Debt/Equity
N/A
Debt/Assets
0.0%
Interest Coverage
N/A
Long-term Debt
N/A

PRFX Revenue Growth, EPS Growth & YoY Performance

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
N/A
Free cash flow / Revenue

PRFX SEC Filings: Latest 10-K & 10-Q Analysis

Access official SEC EDGAR filings for PRF Technologies Ltd. (CIK: 0001801834)

📋 Recent SEC Filings

Date Form Document Action
Aug 26, 2024 SC 13D ea0212371-13dliapure_pain.htm View →
Apr 24, 2024 SC 13G ea0204591-13gintra_pain.htm View →
Feb 14, 2024 SC 13G armistice-prfx123123.htm View →
Feb 16, 2021 SC 13G ea135638-13gmedica3_pain.htm View →
Nov 4, 2020 SC 13G zk2025081.htm View →

Frequently Asked Questions about PRFX

What is the AI rating for PRFX?

PRF Technologies Ltd. (PRFX) has an AI grade of N/A with 0% confidence, based on fundamental analysis of SEC EDGAR filings.

What are PRFX's key strengths?

Claude: Analysis in progress.

What are the risks of investing in PRFX?

Claude: Analysis in progress.

What is PRFX's revenue and growth?

PRF Technologies Ltd. reported revenue of N/A.

Does PRFX pay dividends?

PRF Technologies Ltd. does not currently pay dividends.

Where can I find PRFX SEC filings?

Official SEC filings for PRF Technologies Ltd. (CIK: 0001801834) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is PRFX's EPS?

PRF Technologies Ltd. has a diluted EPS of $0.00.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.

What is PRFX's fundamental grade?

Based on our AI fundamental analysis in July 2026, PRF Technologies Ltd. has a N/A grade with 0% confidence. Review the strengths and risks sections above for full context. This is not investment advice.

Is PRFX stock overvalued or undervalued?

Valuation metrics for PRFX: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

What is PRFX's AI grade for 2026?

Our dual AI analysis gives PRF Technologies Ltd. a combined N/A grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is PRFX's free cash flow?

PRF Technologies Ltd.'s operating cash flow is N/A, with capital expenditures of N/A.

How does PRFX compare to other Healthcare stocks?

Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio N/A (avg: 2).

Top Rated Stocks
AAPL 92% MSFT 92% FAST 92% ANET 88% RDDT 88% KNSL 88% MGRE 88% FIZZ 88% CRDO 87% AVGO 87%
Sector: All Healthcare Stocks →
Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Jul 13, 2026 | Data as of: 2026-07-13 | Powered by Claude AI